option chains Fidelity
Home > Boards > US Listed > Biotechs > Aastrom Biosciences Inc. (ASTM)

The PureGen osteoprogenitor cell allograft facilitates bone fusion,

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
EZ2 Member Profile
Member Level Grandfathered Member
Followed By 174
Posts 169,313
Boards Moderated 6
Alias Born 03/31/01
160x600 placeholder
Current Report Filing (8-k) "Edgar (US Regulatory)" - 4/23/2014 4:38:23 PM
Aastrom Announces Definitive Agreement to Acquire Sanofi's Cell Therapy and Regenerative Medicine Business "GlobeNewswire Inc." - 4/21/2014 8:30:00 AM
Technical Data on Biotech Stocks -- Research on Alexion Pharma, Incyte, Merrimack Pharma, and Aastrom Biosciences "PR Newswire (US)" - 4/14/2014 9:00:00 AM
Aastrom Reports Data and Safety Monitoring Board Recommendation to Continue ixCELL-DCM Clinical Trial "GlobeNewswire Inc." - 4/9/2014 9:00:00 AM
Questcor Pharmaceuticals (QCOR) Shows Strength: Stock Surges 18.7% in Session - Tale of the Tape "Zacks" - 4/8/2014 8:44:01 AM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) "Edgar (US Regulatory)" - 4/4/2014 4:07:01 PM
Notice of Effectiveness (effect) "Edgar (US Regulatory)" - 4/4/2014 6:02:24 AM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) "Edgar (US Regulatory)" - 4/3/2014 5:23:45 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 4/1/2014 4:56:20 PM
Aastrom Announces Appointments of Dr. Ross Tubo as Chief Scientific Officer and Dr. David Recker as Chief Medical Officer "GlobeNewswire Inc." - 4/1/2014 8:30:00 AM
Proxy Statement (definitive) (def 14a) "Edgar (US Regulatory)" - 3/31/2014 4:26:06 PM
Securities Registration Statement (s-1/a) "Edgar (US Regulatory)" - 3/26/2014 5:19:35 PM
Pre-market Biotech Picks -- Research on Merrimack Pharma, Alexion Pharma, Incyte, and Aastrom Biosciences "PR Newswire (US)" - 3/25/2014 11:25:00 AM
Candidate Selection for Clinical Trials, Financial Results, and Patient Enrollments for Phase I Study - Analyst Notes on Synt... "PR Newswire (US)" - 3/25/2014 8:00:00 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) "Edgar (US Regulatory)" - 3/21/2014 4:50:22 PM
Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) "Edgar (US Regulatory)" - 3/20/2014 5:26:57 PM
Aastrom Biosciences to Present at the 2014 Regen Med Investor Day "GlobeNewswire Inc." - 3/19/2014 9:02:00 AM
Aastrom Biosciences Reports Fourth-Quarter and Year-End 2013 Financial Results "GlobeNewswire Inc." - 3/13/2014 4:05:00 PM
Annual Report (10-k) "Edgar (US Regulatory)" - 3/13/2014 4:04:55 PM
Aastrom Biosciences to Host Fourth Quarter 2013 Investor Call on March 13, 2014 "GlobeNewswire Inc." - 3/6/2014 4:05:00 PM
Securities Registration Statement (s-1) "Edgar (US Regulatory)" - 2/10/2014 5:09:49 PM
Aastrom Biosciences Enters Into $15 Million Equity Commitment With Lincoln Park Capital "GlobeNewswire Inc." - 1/27/2014 4:05:00 PM
Peregrine Pharmaceuticals (PPHM) Soars: Stock Adds 14.5% in Session - Tale of the Tape "Zacks" - 1/7/2014 8:57:01 AM
Aastrom Biosciences Granted Composition-of-Matter Patent for Ixmyelocel-T in Australia "GlobeNewswire Inc." - 12/19/2013 9:00:00 AM
Aastrom Biosciences Regains Compliance With NASDAQ Equity Standard Listing Requirement "GlobeNewswire Inc." - 11/15/2013 9:00:00 AM
EZ2 Member Level Grandfathered Member Tuesday, 10/05/10 09:40:31 AM
Re: mkendra post# 2573
Post # of 4133 
Quote:
The PureGen osteoprogenitor cell allograft facilitates bone fusion, and is marketed exclusively by Alphatec Spine.

PureGen is an adult stem cell that provides cellular and growth factors needed for osteogenesis, without the potential complications of autograft.

Applied at the site of a musculoskeletal defect, PureGen mimics the regenerative environment of youthful tissues by increasing the concentration of stem cells available to repair tissue and build bone.


“There are those who don’t know and those who don’t know they don’t know.”

John Kenneth Galbraith
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist